|
Volumn 11, Issue 1-2, 2000, Pages 65-67
|
The intravascular contrast agent Clariscan(TM) (NC 100150 injection) for 3D MR coronary angiography in patients with coronary artery disease
|
Author keywords
Angiography; Contrast agent; Coronary artery disease
|
Indexed keywords
CONTRAST MEDIUM;
ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;
BREATH HOLDING;
CLINICAL TRIAL;
CONFERENCE PAPER;
CORONARY ARTERY DISEASE;
HUMAN;
IMAGE QUALITY;
MAGNETIC RESONANCE ANGIOGRAPHY;
MULTICENTER STUDY;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
SIGNAL NOISE RATIO;
THREE DIMENSIONAL IMAGING;
CONTRAST MEDIA;
CORONARY DISEASE;
HUMANS;
IMAGE PROCESSING, COMPUTER-ASSISTED;
IRON;
MAGNETIC RESONANCE ANGIOGRAPHY;
OXIDES;
|
EID: 0033668461
PISSN: 13528661
EISSN: None
Source Type: Journal
DOI: 10.1016/S1352-8661(00)00116-2 Document Type: Conference Paper |
Times cited : (20)
|
References (15)
|